Webflow Homepage
Veterinarians
Services For
Canine lymphoma & Leukemia
Personalized Prediction Profile
AI-Driven Drug Response Predictions
(Flow Cytometry + PARR included)
Drug Response Predictions
NEW
Personalize anticancer drug treatment decisions with confidence
Immunoprofile
Get accurate diagnostic support from the start (Flow Cytometry + PARR)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Multidrug Sensitivity Genotyping (MDR1)
Identify MDR1 carrier status with ease
Digital Cytology (Add-on)
Confirm lymphoma or leukemia with precision
Services For
FELINE lymphoma & Leukemia
Immunoprofile
Get accurate diagnostic support from the start (PARR + Flow Cytometry)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Digital Cytology (Add-on)
Confirm lymphoma or leukemia with precision
for
veterinarians
Order Services via Vet Portal
Request Sample Reports
See what you will get when you order ImpriMed's services
Request Pricing
Become an ImpriMed Provider
Participate in Our Research
💖 Wall of Love: Customer Reviews
Veterinary Cancer Pioneers Podcast
Contact Us
Pet Parents
LEARN
How It Works
Dog Lymphoma 101
Cat Lymphoma 101
Blog
Content Library
Get Started
Find a Veterinary Oncologist
Talk to Your Veterinarian
Customer stories & Case Studies
ImpriMed Reviews
Discover what other pet parents are saying and how oncologists use ImpriMed's reports
Human Oncology
CRO
Company
Company
Our Science
About Us
Careers
Events
Press
Contact Us
Contact Us
Other Links
ImpriMed Korea
Pricing
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Find a Vet
Get Started
Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Press Releases
ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services from Pets to Humans
Business Wire
Learn More →
In the News
ImpriMed unveils cancer treatment forecast technology
MobiHealthNews
Learn More →
In the News
New research evaluates flow cytometry and PARR as diagnostic support for feline lymphoma
American Animal Hospital Association NEWStat®
Learn More →
Video/Podcast Interviews
From Dogs to Humans: The Power of Precision Medicine with Dr. Lim
Target Cancer Podcast
Learn More →
In the News
Cell-sizing method for high-accuracy feline lymphoma characterisation in veterinary sciences
Veterinary Practice
Learn More →
Press Releases
ImpriMed Unveils Groundbreaking Cell-Sizing Method for High-Accuracy Feline Lymphoma Characterization in Veterinary Sciences
Business Wire
Learn More →
In the News
Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma
DVM360
Learn More →
Scientific Publications
Prognostic Utility of the Flow Cytometry and Clonality Analysis Results for Feline Lymphomas
Veterinary Sciences
Learn More →
In the News
ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market
Pulse 2.0
Learn More →
In the News
New AI Tool Guides Canine Cancer Treatment
Today's Veterinary Business
Learn More →
In the News
New AI service offers personalized drug response predictions for canine patients with cancer
DVM360
Learn More →
In the News
Artificial intelligence poised to transform veterinary care
AVMA News
Learn More →
Press Releases
ImpriMed Launches Innovative AI-Driven Drug Response Predictions (DRP) Service to Guide Tailored Treatments, Meet Rising Demand in Veterinary Oncology
Business Wire
Learn More →
Press Releases
ImpriMed to Showcase Groundbreaking AI Research and Applications at Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)
Business Wire
Learn More →
Press Releases
ImpriMed to Present Innovative Research at 2024 World Veterinary Cancer Congress
Business Wire
Learn More →
Scientific Publications
Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed B-cell lymphoma
Frontiers in Oncology
Learn More →
Press Releases
ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology
Business Wire
Learn More →
In the News
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
TechCrunch
Learn More →
Next
